risperidone / Generic mfg.  >>  Phase 3
Welcome,         Profile    Billing    Logout  

111 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
risperidone / Generic mfg.
NCT00235352: Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia

Completed
2/3
105
US
CX516 (Ampakine)
North Suffolk Mental Health Association, RespireRx
Schizophrenia
04/05
02/07
NCT00063349: Clozapine and Risperidone for Treatment of First Episode Schizophrenia and Cannabis Use Disorder

Suspended
2/3
38
US
Risperidone, Clozapine
National Institute of Mental Health (NIMH)
Schizophrenia, Marijuana Abuse
 
 
NCT00215241: Risperidone Augmentation for PTSD

Completed
2/3
80
US
sertraline and risperidone
Duke University, Janssen Pharmaceuticals
Post-Traumatic Stress Disorder
 
07/06
DM, NCT01189006: Add-On Therapy to Risperidonein Schizophrenia

Completed
2/3
161
RoW
Dextromethorphan
National Cheng-Kung University Hospital
Schizophrenia
12/08
12/08
PG, NCT00584701: Pharmacogenomics in Autism Treatment

Completed
2/3
49
US
Risperidone, Risperdal
University of California, San Francisco, Janssen, LP, National Institute of Mental Health (NIMH)
Autism
05/09
05/09
SMEAC, NCT00910780: Metabolic Effects of Antipsychotic Substitution in Children

Withdrawn
2/3
0
US
Aripiprazole, Zyprexa, Risperdal
Washington University School of Medicine, Pfizer
Diabetes
11/09
11/09
NCT01129674 / 2009-017853-36: A Long-Term, Open-Label, Study on Schizophrenia

Terminated
2/3
1210
Japan, US, RoW
LY2140023, mGlu 2/3 Prodrug II, Olanzapine, Zyprexa, LY170053, Aripiprazole, Risperidone, Quetiapine
Eli Lilly and Company
Schizophrenia
10/12
10/12
NCT01625897: A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia

Completed
2/3
125
Japan
MP-214, Risperidone
Mitsubishi Tanabe Pharma Corporation
Schizophrenia
03/15
03/15
NCT01625000: Safety and Efficacy of MP-214 in Patients With Schizophrenia

Completed
2/3
512
Japan, RoW
MP-214 3mg, MP-214 6mg, MP-214 9mg, Risperidone 4mg, Placebo
Mitsubishi Tanabe Pharma Corporation
Schizophrenia
08/15
10/15
NCT01626872: Long-Term Study of MP-214 in Patients With Schizophrenia

Completed
2/3
254
Japan, RoW
MP-214 3mg, MP-214 6mg, MP-214 9mg, Risperidone 4mg
Mitsubishi Tanabe Pharma Corporation
Schizophrenia
10/16
10/16
2020-006062-36: A Phase II/III, randomized, 4-week, placebo-controlled study, designed to determine the safety, tolerability, and efficacy of evenamide (NW-3509) in patients with chronic schizophrenia.

Ongoing
2/3
196
Europe, RoW
Evenamide, NW3509, Capsule, hard
Newron Pharmaceuticals S.p.A., NEWRON PHARMACEUTICALS SPA, Newron Pharmaceuticals S.p.A, Newron Pharmaceuticals S.p.A., Newron Pharmaceuticals S.p.A
Chronic schizophrenia, Chronic schizophrenia, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
 

Download Options